Trial intelligence / Profile preview

Ferinject in older adults with iron deficiency anaemia

NCT05708170Phase 4Not yet recruiting

Sponsor
Liverpool Hope University
Start
Jan 2023
Primary completion
Aug 2026
Modality
Small Molecules
01

Overview

A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Liverpool Hope University. Planned start Jan 2023; status: not yet recruiting.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT05708170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05708170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call